Physician profile
Steven Powers
NPI 1255318069
$8,393.02
in general payments reported to CMS, 2019-2025
41 companies · $1,512 in 2025
The $1,512 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $433 · 2021: $1,160 · 2022: $1,822 · 2023: $1,495 · 2024: $803 · 2025: $1,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,876 · Travel and Lodging: $675 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,876.35 |
| Travel and Lodging | $675.15 |
| Education | $259.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $1,251.83 | 2019-2025 | Injectafer |
| Abbvie INC. | $1,089.90 | 2019-2023 | |
| Astellas Pharma US INC | $978.46 | 2019-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $675.15 | 2025 | |
| Amgen INC. | $528.38 | 2019-2025 | Evenity, Prolia, Prolia |
| Momentis Surgical INC. | $456.00 | 2022 | |
| Hologic Sales and Service, LLC | $436.40 | 2019-2025 | Acessa Provu System, Novasure, Coolseal Generator |
| Myovant Sciences INC. | $407.29 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $305.75 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $241.69 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $225.41 | 2022-2025 | |
| Organon LLC | $215.40 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $215.01 | 2019-2024 | Wegovy |
| Minerva Surgical, INC | $189.67 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $185.23 | 2019-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.70 | 2019-2024 | |
| Urovant Sciences INC | $108.95 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $104.78 | 2019-2021 | |
| Therapeuticsmd, INC. | $57.13 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $53.01 | 2019-2020 | |
| Scynexis, INC. | $48.90 | 2022 | |
| Avion Pharmaceuticals | $39.04 | 2022-2023 | Balcoltra |
| Shield Therapeutics INC | $36.28 | 2024 | |
| Lupin INC. | $32.65 | 2019 | |
| Meditrina | $32.46 | 2023-2024 | |
| Medtronic, INC. | $29.43 | 2022-2024 | Interstim |
| Vertical Pharmaceuticals, LLC | $28.80 | 2019 | |
| Biogen, INC. | $28.23 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $23.41 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.02 | 2023 | |
| Coopersurgical, INC. | $22.62 | 2019-2020 | |
| Millicent US INC | $19.29 | 2025 | Femlyv, Intrarosa |
| Mimedx Group, INC. | $19.03 | 2025 | |
| Duchesnay USA Incorporated | $18.87 | 2019 | |
| Teleflex LLC | $16.12 | 2020 | |
| Dermira, INC. | $15.85 | 2020 | |
| Alydia Health | $14.60 | 2021 | |
| Renovia INC | $14.25 | 2021 | |
| Aspira Women'S Health INC | $13.30 | 2024 | Ova1 |
| Glaxosmithkline, LLC. | $11.72 | 2019 | |
| Allergan, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.